Health

Gerontech and Innovation Expo cum Summit 2025 20 to 23 November: Showcasing nearly 1000 innovative technology products and solutions to co-create smart ageing future

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The 9th Gerontech and Innovation Expo cum Summit (GIES), co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Council of Social Service (HKCSS), and co-hosted by the Hong Kong Science and Technology Parks Corpora...

2025-11-21 22:58 2220

K-Beauty & K-MediTech Expo Malaysia 2025 Opens to Strong Turnout, Accelerating Cross-Industry Growth in Southeast Asia

PENANG, Malaysia, Nov. 21, 2025 /PRNewswire/ -- K-Beauty Expo Malaysia 2025 and K-MediTech Expo Malaysia 2025, organized by KINTEX, officially opened today at the Penang Waterfront Convention Centre (PWCC), marking a significant milestone as two of Korea's most recognised industry exhibitions deb...

2025-11-21 17:30 1262

Sisram Medical Launches Universkin by Alma in Hong Kong, Pioneering a New Era of AI-assisted Personalized Skincare

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced...

2025-11-21 16:15 967

Hong Kong hosts landmark International Genomic Medicine Symposium

300 Industry Leaders Gather to Drive Medical Innovations and Showcase Hong Kong's Strengths HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The International Genomic Medicine Symposium (Symposium), jointly organised by the Hong Kong Genome Institute (HKGI), Rare Diseases International (RDI), and The La...

2025-11-21 15:49 711

Telix Opens TMS Yokohama in Japan, Commemorative Lecture Held

MELBOURNE, Australia and KYOTO, Japan, Nov. 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the official opening of Telix Manufacturing Solutions (TMS) inYokohama, Japan, the Company's first cyclotron facility in theAsia Pacific region (APAC...

2025-11-21 14:22 2951

NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

* Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program * The ability to attract seasoned ophthalmology leaders highlights the compelling opportunity ...

2025-11-21 13:46 943

Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

* The first patient had received the first dose of EVM14 injection in a global, multi-center Phase I clinical trial of Everest Medicines' Tumor-Associated Antigen (TAA) Cancer Vaccine EVM14 at NEXT Oncology Virginia in the United States, marking an important milestone in its global clinical dev...

2025-11-21 12:01 967

National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations

The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving medicines for patients SINGAPORE, Nov. 21, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes brand and leading provi...

2025-11-21 11:28 831

Colebrook Bosson Saunders Launches Their First Sustainability Report

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- As the world turns its attention to the environment duringCOP30, Colebrook Bosson Saunders (CBS),  the leader in workplace ergonomics, is underscorin...

2025-11-21 09:00 872

PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting

IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted fo...

2025-11-20 23:12 1265

Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth 2026 for the Second Consecutive Year

Ranked in the Top 7% Among More Than 4,000 Global Corporations, Highlighting Leadership in Eco-Friendly Innovation and Responsible Growth SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Kolmar Korea , a global cosmetics ODM leader, has been selected for the secon...

2025-11-20 21:30 1532

Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer

* The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. * The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 cli...

2025-11-20 18:52 1136

Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong

HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients inHong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that po...

2025-11-20 17:34 1105

Smartee Deepens Its Strategy for Central Asia and Russia in 2025

SHANGHAI, Nov. 20, 2025 /PRNewswire/ -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy inCentral Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased it...

2025-11-20 13:53 718

Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed * Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. * This promising new applicatio...

2025-11-20 13:52 658

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...

2025-11-20 10:56 833

WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry

WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients. SAN ANTONIO, Nov. 20, 2025 /PRNewswire/ -- Frost & Sullivan

2025-11-20 10:00 707

USANA Named No. 1 Dietary Supplements Brand in the Philippines for the 7th Consecutive Year

Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand inthe Philippines* by Eurom...

2025-11-20 09:16 697

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] wo...

2025-11-20 03:00 1087

NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices

WASHINGTON, Nov. 20, 2025 /PRNewswire/ -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices inCambodia, thankingCambodia for providing extensive data and relying on science. T...

2025-11-20 01:33 853
1234567 ... 563